Sai Parenteral's Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sai Parenteral's Limited's yearly results, compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than almost all Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
0.4×Debt due within a year is covered 0.4 times by its yearly operating cash.
Lower than 74% of Healthcare companies in India.
Cash Cushion Ratio
−9%Debt, after subtracting cash, equals 9% of its market value (net debt).
Lower than 76% of Healthcare companies in India.
Tangible Assets Ratio
80%Of every ₹100 the company owns, ₹80 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 81% of Healthcare companies in India.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than almost all Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Sai Parenteral's Limited owes ₹0.83 for every ₹1 it owns. Net profit rose 133% in the year to Mar 2025.
Compared with Healthcare companies in India · latest annual results Mar 2025.
P/E ratio
159.2Investors pay ₹159.2 for every ₹1 of Sai Parenteral's Limited's yearly profit, higher than 96% of Healthcare companies in India.
P/B ratio
9.66The share price is 9.66 times Sai Parenteral's Limited's book value per share, higher than 82% of Healthcare companies in India.
Market cap
₹2,040 CrThe total market value of all of Sai Parenteral's Limited's shares at today's price (share price × number of shares), smaller than 65% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹211 CrWhat Sai Parenteral's Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Sep 2025).
Book value per share
₹47.78Net worth divided by the number of shares. The share price of ₹461.70 is 9.7 times this, which is the P/B above.
Return on equity (ROE)
1.9%Sai Parenteral's Limited earned 1.9% on its shareholders' money over the last year, lower than 88% of Healthcare companies in India.
Owes vs Owns
0.83×Sai Parenteral's Limited owes ₹0.83 for every ₹1 it owns (high), higher than almost all Healthcare companies in India.
Dividend yield
NoneSai Parenteral's Limited does not currently pay a dividend.
Revenue growth
+222%Revenue rose 222% in the year to Mar 2025.
Profit growth
+133%Net profit rose 133% in the year to Mar 2025.
Profit margin
4.0%Sai Parenteral's Limited keeps ₹4 of every ₹100 of revenue as net profit.
Cash quality
1.7×Cash from Sai Parenteral's Limited's business was 1.7× its reported profit in the year to Mar 2025 — its profit turned into cash.
Interest cover
1.9×Sai Parenteral's Limited's operating profit covered its interest costs 1.9 times in the year to Mar 2025.
Cash vs debt
Net debtSai Parenteral's Limited had ₹189 Cr more debt than cash (net debt) at Mar 2025.
Questions
What is Sai Parenteral's Limited's P/E ratio?
Investors pay ₹159.2 for every ₹1 of Sai Parenteral's Limited's yearly profit, higher than 96% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sai Parenteral's Limited: ₹2,040 Cr ÷ ₹211 Cr (30 Sep 2025) = 9.7.
What is Sai Parenteral's Limited's return on equity?
Sai Parenteral's Limited earned 1.9% on its shareholders' money over the last year, lower than 88% of Healthcare companies in India.
How much does Sai Parenteral's Limited owe compared with what it owns?
Sai Parenteral's Limited owes ₹0.83 for every ₹1 it owns (high), higher than almost all Healthcare companies in India.
Does Sai Parenteral's Limited pay a dividend?
No. Sai Parenteral's Limited does not currently pay a dividend.
Is Sai Parenteral's Limited's revenue growing?
Revenue rose 222% in the year to Mar 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.